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1. Introduction
  Osteoporosis is a systemic disease meaning low bone 
mass, microstructure damage, skeleton disorder, and 
more fragile bone, leading to an increasing of the bone 
fracture risk. The imbalance of the bone remodeling, about 
bone resorption and formation, seems to be the cause of 
osteoporosis, and the osteoblasts and osteoclasts come to 
be disproportionate[1-3]. Although the RANK/RANKL/OPG 
system has been confirmed[4,5], the detailed pathologic 
mechanism, especially the molecular cause, keeps more 
mystery. With the population life extending and the aging 
society, osteoporosis because of aging bone loss is very 
common in the elderly, threatening the health seriously. 
By now, the treatment of primary osteoporosis generally is 
medicines for correcting the disorder of bone formation and 
resorption. The medicine therapy is a long-term treatment, 
which needs strict adherence[6,7].
  Mesenchymal stem cells (MSCs) from bone marrow have 
the ability for self-renewal, and the potential to differentiate 
into multilineage cells, such as osteoblasts, chondrocytes, 
myocytes, adipocytes, neurons, cardiomyocytes[8-11]. So 
MSCs seem to be the one of greatest therapeutic resources 
for gene therapy, cell therapy and tissue engineering[12-14]. 
MSCs must have life span in vivo and in vitro, the potential 
of multilineage differentiation and self-renewal seems to 
loss with aging. Some studies suggest that there is an age-
related decline of MSC frequency and physiology[15]. It 
has been reported that if MSCs come aging, the balance of 
osteoblastic and adipocytic differentiation is broken, and 
the population of osteoblasts seems to declines[8,16,17]. 
  In the present study, we hypothesized that osteoporosis is 
the result of the aging MSCs. In our study, we established 
an ovariectomized (OVX) osteoporosis rat model, isolated 
MSCs from OVX and normal rats, and characterized MSCs 
in vitro. We report that the MSCs from osteoporosis rat 
have less proliferation potency and impaired osteogenic 
Objective: To explore decreased proliferation ability and differentiation potential of mesenchymal 
stem cells (MSCs) of osteoporosis rat.  Methods: MSCs were obtained from osteoporosis rat, 
and proliferation potency and impaired osteogenic differentiation potential were determined. 
Results: The result showed a significant downregulation of MSCs pluripotency related gene (Oct 
4) and osteogenic genes (BSP, OCN) expression in OVX MSCs compared with Sham MSCs (P<0.05). 
Conclusions: These data suggest that MSCs are aging in osteoporosis body, and autologous 
OVX MSCs transplantation is not appropriate to treat osteoporosis if necessary. There will be a 
possibility in establishing a new clinical application of MSCs autologous transplantation to treat 
osteoporosis, if OVX MSCs have stronger proliferation and differentiation.
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differentiation potential. These data suggest that MSCs 
are aging in osteoporosis body, and autologous OVX MSCs 
transplantation is not appropriate to treat osteoporosis if 
necessary.
2. Materials and methods
2.1. Development of osteoporosis rat model
  Female Sprague Dawley rats (6-9 months old) were used for 
establishing an OVX osteoporosis rat model. Chloral hydrate 
(100 mg/mL) 350 mg/kg was injected into abdominal cavity 
to induce and maintain anesthesia. Rats were randomly 
divided into two groups: OVX group (n=7) and Sham group 
(n=7). OVX operation had two longitudinal incisions along 
both sides of the spine. After having ligated the ovarian 
vessels and fallopian tubes, the bilateral ovaries were 
excised. The Sham group was performed the same operation, 
but only the periovarian fat pads were removed. The mass 
which was removed had a histopathological examination to 
confirm ovary excision. Bone mineral density (BMD) of the 
femurs of two groups was measured by dual energy X-ray 
absorptiometry (Hologic Corporation, Discovery Wi) 3 months 
postsurgery to confirm the osteoporosis status. The uterus 
weight was measured at the same time, and histopathologic 
examination of the femurs was done as well.
2.2. Isolation and culture of bone marrow MSCs
  MSCs of the Sham group and OVX group were isolated 
from bone marrow of femur and tibia. Separation of muscles 
and tendons from femurs and tibias was done before MSCs 
isolation. MSCs culture medium (Cyagen Bio, China) was 
used to flush the marrow cavity of femurs and tibias. Until 
the bone seemed white, the bone marrow was washed out 
completely. The culture medium used to flush containing 
MSCs was collected, eliminating the thrombus, and seeded 
into 25 cm2 flasks. MSCs were adherent to the bottom of the 
flask by their adherence characteristic. Culture medium was 
changed at 24, 48, and 72 h to isolate MSCs from other types 
of nonadherent cells. The nonadherent cells were washed 
out from the flask by changing culture medium. MSCs were 
cultured in an incubator at 37 曟 with 95% air and 5% CO2. 
The medium was replaced every 3 days. After 7-10 days 
culture, when the cells reached 70% confluency, they were 
trypsinized and passaged.
2.3. Flow cytometry analysis
  Cells were trypsinized at the time of 90% confluency, 
and centrifuged at 244 g for 4 min. The supernatant was 
discarded. 3.0伊104 cells were resuspended in 100 毺L buffer 
which was phosphate-buffered saline (PBS) solution with 
1% bovine serum albumin. Cells were incubated in the dark 
with antibody for PE anti-rat CD45, PE CD34, Mouse anti-
rat CD44 PE, PE anti-mouse/rat CD29 (all from Biolegend) at 
4 曟 for 30 min. Then cells were washed and resuspended 
with buffer , analyzed with flow cytometry (FACSCalibur, BD, 
USA).
2.4. Cells morphology and growth curve
  Cells of two groups were examined with an inverted phase 
contrast microscope (Olympus IX50, Olympus, Japan). A 
growth curve was described with a counting chamber. Cells 
were trypsinized at the time of reaching 70% confluency, and 
centrifuged at 244 g for 4 min. Cells were resuspended in 
the culture medium, and seeded into the 6-pore plate at the 
initial concentration of 2.1伊103/cm2. At 1st, 2nd, 3rd, 4th, 5th, 
and 6th day of culture, the cells in one pore were trypsinized 
and counted.
2.5. Osteogenic differentiation of MSCs
  Cells were plated at a concentration of 3.1伊103/cm2 on 
6-pore plate with MSCs culture medium (Cyagen Bio, 
China), incubating at 37 曟 with 95% air and 5% CO2. When 
cells were 50%-70% confluency 24 h later, the medium was 
changed by 2 mL Osteogenic differentiation medium (Cyagen 
Bio, China) every pore. The osteogenic differentiation 
medium was replaced every 2 days. On the 10th day of 
osteogenic differentiation, cell samples were collected for 
reverse-transcription PCR. And on the 21st day of osteogenic 
differentiation, cells were stained with alizarin red S.
2.6. Alizarin red S staining
  On the 21st day of osteogenic differentiation, medium was 
discarded. And cells were washed by PBS solution twice. 
Then cells were fixed with 4% neutral buffered formalin for 
30 min. Then cells were washed with PBS and stained with 
1ml alizarin red S each pore for 3-5 min. The pores were 
washed by PBS, and calcium nodules were stained and 
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visible under microscope.
2.7. Reverse-transcription and RT-PCR
  When cells were normal culture for 14 days or osteogenic 
differentiation culture in 10 days, total RNA was extracted 
and isolated with RNAprep Pure Cell Kit (TIANGEN, Beijing, 
China) according to the manufacturer’s instrucions. The 
total RNA was dissolved in DEPC H2O,and stored at -20 曟.
As reverse-transcription, cDNA was synthesized from 
1 毺g total RNA with Oligo-dT (50 pmoles) and random 
primer (50 pmoles) using AccuPower® RocketScriptTM RT 
PreMix (BIONEER, Korea) according to manual’s protocol. 
The PCR reactions were performed by using 25 毺L 2伊
Es Taq MasterMix  (CWBIO, China ) in a 50 毺L reaction 
mixture with cDNA 1 毺L and 20 pmoles of forward and 
reverse primers (sequences are shown in Table 1). PCR 
products were separated by 2% agarose gel electrophoresis 
and visualized by ethidium-bromide staining with a gel 
documentation system of ChampGel 5500 (Sage Creation, 
Beijing). The band intensities of gel image were quantitated 
with Scion Image (IBM PC, USA).
Table 1
PCR primer sequences.
Gene Primer sequences Size of product (bp)
Actin F 5’-AGACCTTCAACACCCCAGC-3’ 260
F 5’-GTCACGCACGATTTCCCT-3’
Oct 4 F 5’-GGACACCTGGCTTCAGACTT-3’ 197
R 5’-ATCCCTCCACAGAACTCGTATG-3’
OCN F 5’-ACAAGTCCCACACAGCAACTC-3’ 103
R 5’-CCAGGTCAGAGAGGCAGAAT-3’
BSP F 5’-AAAGAGCAGCACGGTTGAGTAT-3’ 175
2.8. Statistical analysis 
  Statistical analysis was performed using SPSS software 
for Windows (SPSS statistics 21, IBM, USA). All data are 
expressed as the mean依standard deviation (SD). Analysis 
of variance (ANOVA) was used for statistical comparisons 
between different groups. P<0.05 was taken to indicate 
statistical significance.
3. Results
3.1. Establishment of osteoporosis rat model
  All rats both the OVX group (n=7) and the Sham group (n=7) 
survivd as there were no postoperative complications and 
infection. OVX caused the changes to the level of ostrogen 
and bone metabolism, leading to the decrease of weight, 
uterus weight and BMD. The average weight of the OVX 
rats was (417.29依33.20) g at 3 months postoperatively, which 
of the Sham group was (430.42依36.23) g (P<0.05). There 
was the significant difference in the OVX group between 
preoperative and postoperative weight [(443.14依40.27) g] 
(P<0.05), while the difference was not significant in Sham 
group [(434.29依45.42) g]. BMD of the OVX group was (0.199
依0.006) g/cm2 and (0.238依0.015) g/cm2 for the Sham rats 
(P<0.05). The difference of uterus weight/body weight ratio 
between two groups was significant as well, (0.039依0.010)% 
for the OVX and (0.058依0.006)% for the Sham. The results of 
histopathologic examination showed that a significant bone 
loss in the OVX group, and there were full of erode-like 
cavities in bone tissues (Figure 1).
A B
Figure 1. Bone histopathologic examination of the femurs of OVX and 
Sham rats, 伊40. (A) OVX group; (B) Sham group.
3.2. Flow cytometry analysis
  After initial cell culture, the results of flow cytometry 
analysis showed that both OVX and Sham MSCs from the 
bone marrow showed positive responses to MSCs markers 
like CD29, CD44. Also they showed cells were negative for 
the hematopoietic markers such as CD34, CD45. Positive 
CD29 and CD44 were 99.86% and 88.04%, respectively in 
OVX group, 99.86% and 99.47% in Sham group. Positive CD34 
and CD45 were 0.10% and 0.14%, respectively in OVX group, 
0.64% and 0.35% in Sham group. All of these results showed 
those cells conformed to MSCs.
3.3. Cells morphology and growth curve
  Primary MSCs from Sham rats and OVX rats were examined 
after 14 days culture. The results showed that compared 
to Sham MSCs, OVX MSCs were slenderer, more nuclear 
concentrated, and more intercellular spaced (Figure 2). In 
the same time of culture, the OVX MSCs also showed lower 
colony-forming rate and growth rate. According the growth 
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curve (Figure 3), OVX MSCs showed a lower proliferation rate 
than the Sham (P<0.05). And there was no peak of population 
for the OVX in 7 days culture, while the Sham MSCs had a 
top of ( 6.75依0.31)伊105 at the 4th day.
A
B
 
Figure 2. Cells morphology of OVX and Sham primary MSCs after 14 
days culture, 伊40. (A) Sham MSCs; (B) OVX MSCs.
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Figure 3. Grouth curve of OVX MSCs and normal MSCs.
3.4. Charaterization and Osteogenic differentiation of MSCs
  To examine the MSCs pluripotency, we made RT-PCR 
analysis of Oct4 when cells were normal culture by 14 days. 
RT-PCR revealed the downregulation of Oct 4 in OVX MSCs 
compared with Sham (Figure 5). And these were associated 
with differentiation of MSCs. We also chose RT-PCR analysis 
of bone sialoprotein (BSP) and osteocalcin (OCN) gene with 
the 10 days osteogenic differentiation cultured MSCs. The 
result showed a significant downregulation of osteogenic 
genes (BSP, OCN) expression in OVX MSCs compared with 
Sham MSCs (P<0.05).
  With 21 days of osteogenic differentiation, nodule 
formation was examed by alizarin red S stain (Figure 4). The 
results showed that OVX MSCs formed less calcium nodules 
compared with Sham MSCs in the same area, and OVX MSCs 
had decreased osteogenic differentiation potential.
 
Figure 4. OVX and Sham MSCs stained by Alizarin red S after 21 
days osteogenic differentiation culture, 伊200. (A) Sham MSCs; (B) 
OVX MSCs.
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Figure 5. Differental gene expression between OVX and Sham MSCs. 
RT-PCR analysis of MSCs pluripotency related gene (Oct 4) and 
osteogenic differential genes(BSP, OCN), P<0.05.
4. Discussion
  With the population life extending and the aging society, 
the number of the patients with osteoporosis is increasing. 
Autologous MSCs transplantation may be a potential strategy 
to increase bone formation in osteoporosis patients, if their 
MSCs have nice ability of proliferation and differentiation[18-20].
To make sure the probablity, in the present study, we have 
demonstrated osteoporosis rat model establishment, MSCs 
isolation, and characterized MSCs in vitro. Rat model has 
been used as a substitute for human patients in the study 
of bone defects[21], cerebral infarction[22], myocardial 
ischemia[23]. OVX models appear to undergo the same 
bone remodeling as estrogen-deficiency osteoporosis in 
postmenopausal women. Porcine and canine models are 
inappropriate for study of osteoporosis because they have 
little bone loss after OVX[24,25]. Rat models need less time to 
achieve osteoporosis compared with 6 months of rabbits[26]. 
In our study, we established rat osteoporosis model after 
OVX 3 months. Initial cell culture had difficulties such 
as lower proliferation rates. We successfully cultured 
MSCs from the OVX rats to examine the proliferation and 
differentiation potentials.
  Currently, the mainly accepted mechanism of osteoporosis 
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is that the number and activity of osteoblasts reducing, 
the number and activity of osteoclasts increasing result in 
decreased bone formation and increased bone resorption. 
Osteoblasts derive from MSCs, indicating MSCs are one 
of the keys to osteoporosis. MSCs have the ability to self-
renewal and differentiation in multiple lineages. Since MSCs 
have pluripotency of multiple tissues in vitro and vivo, they 
are usually attached to cell and gene therapy.
  As a result, it is necessary to evaluate the proliferative 
capacity and differential ability to maintain the treatment 
after MSCs transplant. In our study, OVX MSCs had a lower 
proliferation rate than Sham MSCs, in the 7 days culture. The 
key point may be telomerase reverse transcriptase (TERT). 
TERT can improve the activity of telomerase to extend 
telomere lengths and maintain telomere stable when cell 
division making telomere short. That makes cell proliferation 
enhanced and cell life span extended. However it reported 
that in MSCs the expression of TERT was rarelly[27-29], 
causing telomerase activity limited leading to MSCs aging[30].
And they also had a weaker osteogenic differentiation than 
the normal. Oct4 as a embryonic transcription factor is 
normally expressed in ESCs to enhance self-renewal and 
pluripotency, which can be examined to evaluate stem-
like properties loss in MSCs[31]. And an increase of Oct4 
expression was reported in MSCs during differentiation[32]. 
Therefore we checked the semi-quantative RT-PCR analysis 
of Oct4 in OVX and Sham MSCs. Results revealed that 
lower mRNA levels of Oct4 in OVX than Shan, suggesting 
loss of stem-like and differential properties in the OVX 
MSCs. In our study, we also examined the expression of 
osteogenic differential marker genes such as BSP, OCN[33,34] 
after 10 days osteogenic differentiation culture. We noted a 
significant downregulation of expression for these genes in 
OVX MSCs compared with Sham, suggesting that OVX MSCs 
had a lower osteogenic differential ability.
  Although autologous MSCs transplantation was reported 
to treat osteoporosis, there are many difficulties remaining 
in future clinical applications. In our study, we revealed 
that OVX MSCs had lower proliferative capacity and weaker 
osteogenic differentiation than normal MSCs, which made 
it inappropriate for autologous transplantation treatment. 
There will be a possibility in establishing a new clinical 
application of MSCs autologous transplantation to treat 
osteoporosis, if OVX MSCs have stronger proliferation and 
differentiation.
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